Bedón GR, Veloz OX, Escalona CA

Language: Spanish
References: 15
Page: 1-7
PDF size: 294.25 Kb.

ABSTRACT

Introduction: Bacterial endocarditis is a rare disease, caused in most cases by gram-positive organisms, such as staphylococci and streptococci, followed by HACEK group organisms and rarely by non-HACEK gram-negative organisms. Its incidence is low, but it is related to high mortality; there are several associated risk factors: advanced age, female sex, history of heart surgery, prosthetic valves, use of central venous or urinary catheters.v Objective: To describe the available evidence on bacterial endocarditis due to Escherichia coli.
Case report: We describe the case of an elderly patient, without a history of cardiac surgery, who showed disorientation, asthenia, adynamia, elevation of body temperature, associated with urinary infection, persisting after taken piperacillin-tazobactam for 7 days with temperature rises. Blood cultures confirm Escherichia coli bacteremia and transesophageal echocardiography exhibited vegetation at the native aortic valve level. The patient received antibiotic treatment with third-generation cephalosporin for 30 days, with clinical improvement, echo transesophageal control with no vegetations, and no immediate need for surgical treatment.
Conclusions: The clinical suspicion of endocarditis is vital when requesting diagnostic tests and interpreting their results.

REFERENCES

1. Baddour L, Wilson W, Bayer A. Infective Endocarditis in Adults: diagnosis, antimicrobial therapy,and management of complications. Circulation. 2015;132(15):1435-86.

2. Sociedad Argentina de Cardiología. Consenso de endocarditis infecciosa. Revista Argentina deCardiología. 2016; 84(Suplemento 5):1-49.

3. Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el tratamiento de laendocarditis infecciosa. Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa. Rev EspCardiol. 2016;69(1):69:1-49.

4. Burgos L, Oses P, Iribarren A. Endocarditis infecciosa por bacilos gram negativos no HACEK.Experiencia en un centro de alta complejidad de la República Argentina (1998-2016). Rev ArgentMicrobiol. 2019;51(2):136-9.

5. Conde J, Camacho C, Quintana M. Endocarditis infecciosa. Rev Hosp Jua Mex. 2017;84(3):143-66.

6. Jamal M, Ahmad W, Andleeb S. Bacterial biofilm and associated infections. Chinese MedicalAssociation. 2018;81(1):7-11.

7. O’Connor C, O’Rourke S, Buckley A. Infective endocarditis: a retrospective cohort study. QJM:An International Journal of Medicine. 2019;112(9):663-7.

8. Noureddine M, De La Torre J, Ivanova R. Endocarditis sobre válvulas izquierdas por bacilos grannegativos: epidemiología y características clínicas. Enferm Infecc Microbiol Clin. 2011;29(4):276-81.

9. Nogueira A, Brazão S, Ferreira D, Aragão A, Teixeira M, Carvalho A. Escherichia coli endocarditisof a native mitral valve. IDCases. 2019;17(e00548):1-2.

10. Menon T, Balakrishnan N, Somasundaram S, Dhandapani P. Native valve endocarditis causedby Escherichia coli. J Clin Diagn Res. 2017;11(6): DD05-DD06.

11. Ertugrul M, Arslan F, Ozyavuz S. Non-HACEK gram-negative bacillus endocarditis. Med MalInfect. 2019;49(8):616-20.

12. Chen C, Lin Z, Yu W, Wu W. Escherichia coli endocarditis of native aortic valve and mitralvalve. J Formos Med Assoc. 2015;114(9):893-4.

13. Akuzawa N, Kurabayashi M. Native valve endocarditis due to Escherichia coli infection: a casereport and review of the literature. BMC Cardiovasc Disord. 2018;18(195):1-9.

14. Durante E, Franc M, Tripodi O, Albisinni R, Utili R. Management of gram-negative and fungalendocarditis. J Antimicrob Agents. 2010;36(2):40-5.

15. Rangarajan D, Ramakrishnan S, Patro Kc, Devaraj S, Krishnamurthy V, Kothari Y, et al. Nativevalve Escherichia coli endocarditis following urosepsis. Indian J Nephrol. 2013;23(3):232-4.